Valbenazine Will Be Used to Reduce Tardive Dyskinesia Symptoms

Valbenazine (Ingrezza, in-GREH-zah) will be the first med approved to treat tardive dyskinesia.

Up to 30% of patients on long-term antipsychotics develop tardive dyskinesia...involuntary lip smacking, facial grimaces, etc.

It's usually associated with higher doses, longer durations, and higher-potency typical antipsychotics, such as haloperidol.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals